Illness	Number of cases
Parkinson disease (G20.11)	490
Parkinson disease (G20.21)	75
Dorsalgia - Radiculopathy lumbar region (M54.16)	25
Disturbances of skin sensation - Paresthesia of skin (R20.2)	25
Other degenerative diseases of basal ganglia - Progressive supranuclear ophthalmoplegia Steele-Richardson-Olszewski (G23.1)	19
Secondary parkinsonism - Vascular parkinsonism (G21.4)	14
Other mental disorders due to brain damage and dysfunction and to physical disease (F06.7)	11
Secondary parkinsonism - Other secondary parkinsonism (G21.8)	11
Chronic inflammatory disease of the nervous system - multiple sclerosis (G35.11)	10
Chronic inflammatory disease of the nervous system - multiple sclerosis (G35.31)	9

Top 10 treatments

Treatment	Number
(Neuro-)psychological assessment or establishing the psychosocial background such as financial, occupational and family situation (1-901.0)	1.178
Examination of nerve conduction - ENG (1-206)	633
Patient education (9-500.0)	476
Measurement of the brain waves - EEG (1-207.0)	444
Interdisciplinary management other chronic illnesses (8-97d.1)	412
Measurement of the electrical activity of the heart without a tube (catheter) inserted into the heart via an artery (1-266.x)	363
Treatment of physically or functionally induced disorders of speech, language, the voice or swallowing (9-320)	362
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.2)	317
Measurement of smell and taste (1-247)	269
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.4)	179

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
9	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility